Another limitation was the lack of analysis of the genetic variation of IFITM1 and IFITM3 genes and experimental assays of viral inhibition by these genes in specific conditions of infection with influenza A and SARS-CoV-2 virus. The gene discussed is IFITM3; the disease is influenza.